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During embryonic development, oligodendrocyte progenitors (OLPs) originate from the ventral forebrain under the regulation of Sonic
hedgehog (Shh). Shh controls the expression of transcription factor Olig2, which is strongly implicated in OLP generation. Studies of mice
deficient in Shh expression suggest, however, that an alternative pathway for OLP generation may exist. The generation of OLPs in dorsal
forebrain has been suggested since treatment of dorsal–neural progenitor cells in culture with fibroblast growth factor (FGF-2) results in OLP
induction. To ask if dorsal induction of OLPs in embryonic forebrain can occur in vivo and if FGF-2 could initiate an alternative pathway of
regulation, we used in utero microinjection of FGF-2 into the lateral ventricles of mouse fetal forebrain. A single injection of FGF-2 at E13.5
resulted in the expression of the OLP markers Olig2 and PDGFRα mRNA in dorsal forebrain ventricular and intermediate zones. However, FGF-2
did not induce dorsal expression of Shh, Patched1 or Nkx2.1, and co-injection of FGF-2 and a Shh inhibitor did not attenuate the induction of
Olig2 and PDGFRα, suggesting that Shh signaling was not involved in this FGF-2-mediated dorsal induction. These results demonstrate that the
dorsal embryonic forebrain in vivo has the potential to generate OLPs in the presence of normal positional cues and that this can be driven by
FGF-2 independent of Shh signaling.
© 2006 Elsevier Inc. All rights reserved.Keywords: Fibroblast growth factor-2; Oligodendrocyte; Olig2; PDGFRα; Sonic hedgehog; Nkx2.1; Dlx2; Patched1; MyelinIntroduction
The mammalian CNS develops from self-renewing stem
cells that generate neurons, astrocytes and oligodendrocytes
(OLs) under the regulation of a variety of extrinsic signals. The
developmental origins of OLs have been extensively investi-
gated in the spinal cord (Miller, 2002, 2005; Richardson et al.,
2000; Spassky et al., 2000; Rowitch et al., 2002; Cai et al.,
2005; Fogarty et al., 2005; Vallstedt et al., 2005), and their
origins in the mouse embryonic forebrain are under continuing⁎ Corresponding author. Fax: +1 860 679 8140.
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doi:10.1016/j.ydbio.2006.05.017investigation (Spassky et al., 1998, 2001; Tekki-Kessaris et al.,
2001; Nery et al., 2001; Gorski et al., 2002; Yue et al., 2006;
Kessaris et al., 2006; Nakahira et al., 2006). As in the spinal
cord, a population of OL progenitors (OLPs) originate within
specific ventral locations in the forebrain (Tekki-Kessaris et al.,
2001; Ross et al., 2003). These cells then migrate to dorsal
regions, sequentially maturing through a series of stages that
include proliferative early progenitors (PDGFRα+), late
progenitors or proligodendroblasts (O4-positive) and finally
post-mitotic, terminally differentiated myelinating OLs
(Warrington and Pfeiffer, 1992; Pfeiffer et al., 1993; Pringle
and Richardson, 1993; Woodruff et al., 2001; Miller, 2002;
Sauvageot and Stiles, 2002; Miller and Reynolds, 2004;
Goldman, 2005). Sonic hedgehog (Shh) plays a critical role in
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2001; Tekki-Kessaris et al., 2001; Fuccillo et al., 2004) and
patterns the ventral telencephalon by controlling the expression
of a panel of transcription factors, including Pax6, Dlx2, Nkx2.1
and the basic helix–loop–helix transcription factors Olig1 and
Olig2. Olig2 is essential for neural progenitor cells to
differentiate into OLs and motor neurons in the spinal cord
and into OLs in the forebrain (Lu et al., 2000, 2002;
Takebayashi et al., 2000, 2002; Zhou et al., 2000; Yue et al.,
2006; reviewed by Rowitch et al., 2002).
Fibroblast growth factor-2 (FGF-2) exerts important effects
in culture on the proliferation, migration and differentiation of
OLPs and the conversion of mature OLs to a novel phenotype
(reviewed in Bansal, 2002; Bansal and Pfeiffer, 1997; Fortin
et al., 2005). Furthermore, in culture, FGF-2 can also induce
the generation of OLPs from dorsally derived neural precursor
cells from both the embryonic spinal cord and cerebral cortex
(Gabay et al., 2003; Chandran et al., 2003; Kessaris et al.,
2004; Abematsu et al., 2006). In one study, FGF-2 induced
Shh expression, promoting a “ventralization” of dorsal neural-
stem-cell-derived neurospheres from spinal cord (Gabay et al.,
2003). In another study, FGF-2 induced OLP generation
independent of the Shh pathway (Chandran et al., 2003).
These reports have shown that, at least in vitro, under the
influence of FGF-2, dorsal neural precursor/stem cells have
the potential to differentiate into not only astrocytes/neurons
but also oligodendrocytes. However, in vivo, early embryonic
dorsal neural precursor/stem cells do not appear to generate
OLPs in spite of the fact that FGF-2 and its receptors are
expressed prominently by cells lining both the ventral and
dorsal telencephalic ventricles (Raballo et al., 2000; Bansal
et al., 2003). One explanation is that there are factors in the
dorsal forebrain that are inhibitory for the induction of OLPs
by FGF-2. These factors could be diluted by culturing the
cells, releasing the inhibition. Second, the exposure of cells to
FGF-2 in culture could result in deregulated positional
identity of dorsal neural progenitors (Gabay et al., 2003);
potency of progenitors isolated from a given position of the
CNS may reflect an acquired property from exposure to FGF-
2 in vitro, rather than revealing their endogenous capacity in
vivo. Therefore, whether OLPs can be induced from the
embryonic dorsal forebrain by FGF-2 in vivo remained to be
investigated.
We have addressed this question by examining the effect
of in utero microinjection of FGF-2 into the lateral ventricles
of the E13.5 pups followed by analysis for OLP generation in
the dorsal forebrain at E15.5. We observed that FGF-2
induced the expression of Olig2 and PDGFRα in the cortical
ventricular zone (VZ) of the dorsal forebrain and increased
their numbers in the cortical intermediate zone (IMZ). This
demonstrates that, even in the milieu of the in vivo
environment, and without losing their positional identity,
embryonic dorsal neural stem/precursor cells can generate
OLPs under the influence of increased levels of FGF-2. Since
this was not suppressed by co-injection of Shh inhibitor and
was not accompanied by the induction of Shh, Patched1 or
Nkx2.1 genes, a role for FGF-2 signaling in the generation ofOLPs in the embryonic dorsal forebrain independent of Shh
signaling is suggested.Materials and methods
Microinjection
ICR strain mice (SLC, Japan) were used throughout the studies. Pregnant
mice were deeply anesthetized by intraperitoneal injection of 2% ketamine/0.2%
xylazine in phosphate-buffered saline (PBS) at 0.1 ml/10 g body weight. After
cleaning the abdomen with 70% ethanol, a 1–2 cm midline laparotomy was
performed, and the uterus was taken out. Total volume of 1 μl, including 0.05%
fast green, was microinjected through the uterus into the lateral ventricles of
E13.5 fetal brains using a glass micropipette (type G-1, Narishige, Japan). Half
of the embryos in the uterus were injected with the vehicle solution, 1% bovine
serum albumin (BSA)/PBS and the other half with FGF-2 (100 μg/ml in 1%
BSA/PBS; Sigma, St. Louis, MO, USA). Similarly, in another set of experiment,
half of the embryos in uterus were injected with vehicle solution (1% BSA, 10%
EtOH/PBS) and the other half with FGF-2 (100 μg/ml) plus cyclopamine
(100 μM; Biomol, USA). After microinjection, the uterus was placed back into
the abdominal cavity, and the surgical incision in the mother was closed to allow
embryonic development in utero to continue. The fetal brains were harvested at
E15.5 or E16.5.
Electroporation
In utero electroporation was performed using a Cre/loxP system as described
previously (Nakahira et al., 2006). ROSA-GAP43-EGFP reporter mice were
used for electroporation. The ROSA-GAP43-EGFP reporter mouse carries a
GAP43-EGFP fusion gene with downstream transcriptional stop signals flanked
by two loxP sites in the ROSA26 locus. pCX-Cre vector contains the nuclear
localization signal fragment and Cre recombinase fragment under the control for
the cytomegalovirus immediate early enhancer and chick β-actin promoter
(CAG promoter). Once Cre recombinase is expressed, the transcription STOP
signals are removed, and the GAP43-EGFP fusion gene starts to be expressed
under the control of the ROSA26 promoter in the transformed cells. pCX-Cre
was purified using the plasmid maxi prep kit (Marligen, USA) and dissolved in
PBS. The DNA solution was mixed with an equal volume of 2% BSA/PBS with
or without FGF-2 (final concentration; pCX-Cre 3 μg/ml, FGF-2 100 μg/ml).
DNA solution (1 μl) was injected into lateral ventricles of embryonic forebrain
at E13.5 through the uterus. After injection, the embryo in the uterus was placed
between the electrodes (CUY661-3X7 with CUY661N, NEPA GENE). An
electroporator (CUY21, NEPA GENE) was used to deliver six 50-ms pulses of
33–35 V, with 75-ms intervals. The uterus was placed back into the abdominal
cavity for continued embryonic development.
Tissue preparation
Pregnant mice were deeply anesthetized with pentobarbital, and their
offspring were removed from the uterus. The pups were perfusion-fixed through
the heart with 4% paraformaldehyde (PFA) in PBS, brains were removed and
post-fixed overnight in 4% PFA/PBS at 4°C. Following overnight cryoprotec-
tion in 20% sucrose/PBS, the brains were embedded in OCT compound (Sakura
Finetechnical Co. Ltd., Tokyo, Japan) and quickly frozen on dry ice. Brains were
sectioned coronally (18-μm thicknesses) by a cryostat (Leica CM 3050; Leica,
Bensheim, Germany) and thaw-mounted onto RNAse-free MAS-coated glass
slides (Matsunami Glass, Japan). These sections were used for in situ
hybridization and immunohistochemistry.
In situ hybridization
In situ hybridization was performed as described previously (Ding et al.,
2005). Briefly, the sections were treated with proteinase K (1 μg/ml, 15 min,
room temperature) and hybridized overnight at 65°C using digoxygenin-labeled
antisense riboprobes in a hybridization solution consisting of 50% formamide,
20 mM Tris–HCl pH 7.5, 600 mM NaCl, 1 mM EDTA, 10% dextran sulfate,
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were then washed three times in 1× SSC (150 mM NaCl, 15 mM trisodium
citrate) containing 50% formamide at 65°C followed by maleic buffer (0.1 M,
pH 7.5) containing 0.1% Tween 20 and 0.15 M NaCl. The bound DIG-labeled
probe was detected by overnight incubation of the sections with anti-DIG
antibody conjugated to alkaline phosphatase (1:2000; Roche, Indianapolis, IN,
USA) and color developed in the presence of 4-nitroblue tetrazolium chloride, 5-
bromo-4-chloro-3-indolylphosphate and levamisole in the dark at room
temperature. The sections were washed in PBS and counterstained with fast
red and mounted with Permount (Fisher Scientific, Pittsburgh, PA, USA) after
dehydration. The following probes were used: mouse Olig2 (Takebayashi et al.,
2000), PDGFRα (Ma et al., 2006), Nkx2.1 (Furusho et al., 2006), Dlx2
(Genbank accession number; NM010054), Shh (Echelard et al., 1993) and
Patched1 (NM008957). Digoxygenin-labeled single-stranded riboprobes were
prepared by transcription of linearized plasmids using T7, T3 or Sp6 RNA
polymerase and DIG RNA labeling kit (Roche).
Immunohistochemistry
Following the incubation with a blocking buffer (10% normal goat serum,
1% BSA, 0.1% Triton-X100/PBS), the sections were incubated with the primary
antibodies: rat anti-GFP monoclonal (1:1000) (Nakalai Tesque, INC) and rabbit
anti-Olig2 polyclonal (1:100) (IBL, Japan) antibodies at 4°C overnight. After
washing with PBS, they were incubated for 1 h with Alexa 488-conjugated anti-
rat IgG (1:1000) and Alexa 594-conjugated anti-rabbit IgG (1:1000).
Detection of cell proliferation
To identify cells that were in the S phase of the cell cycle, pregnant mice
received an intraperitoneal injection of bromodeoxyuridine (BrdU; 50 μg/g
body weight) for incorporation into newly synthesized DNA and embryos
collected 2 h later. Sections on glass slides were heat-treated (95°C) in citrate
buffer (10 mM, pH 6.0) for 40 min. Following incubation with blocking buffer
(10% normal goat serum, 1% BSA, 0.1% Triton-X100/PBS), the sections were
incubated overnight with mouse anti-BrdU (1:3000; Pharmingen, San Diego,
CA, USA) at 4°C. After wash with PBS, they were incubated for 1 h with anti-
mouse IgG conjugated to Alexa 488 (1:1000; Molecular Probe, Eugene, OR,
USA).
Explant culture
Ventricular and subventricular zone (VZ/SVZ) explants were prepared by a
procedure described previously with slight modifications (Kawaguchi et al.,
2004). The dorsolateral part of the cerebral cortical wall (see Fig. 3B) was
dissected from E15.5 mouse embryos in a serum-free media (Tropepe et al.,
1999; 1:1 mixture of Dulbecco's modified Eagle' medium (DMEM; Gibco,
Grand Island, NY, USA) and F-12 nutrient (Gibco), 0.6% glucose, 2 mM
glutamine, 3 mM sodium bicarbonate, 5 mM HEPES buffer, insulin (25 μg/ml),
transferrin (100 μg/ml), progesterone (20 nM), putrescine (60 μM) and selenium
chloride (30 nM)). The explants were cultured in this serum-free media on glass
coverslips coated with Matrigel basement membrane matrix (BD Biosciences,
San Jose, CA, USA). After 2 or 3 days, the explants were immunolabeled with
O4 antibody (1:20; Ono et al., 1995) for 1 h at 37°C. Explants were washed with
PBS and fixed in 4% PFA. After treatment with blocking buffer, explants were
incubated with an anti-mouse IgM conjugated to Alexa 488 for 1 h (1:1000,
Molecular Probe, Eugene, OR, USA). Cultures were counterstained with
Hoechst 33342 (1 μg/ml; Sigma). Explants were then washed with PBS and
mounted onto glass slides in Fluorescent mounting medium (Dako Cytomation,
Carpinteria, CA, USA).
Comparative analyses of vehicle- or FGF-2-injected mice
Five to twenty one mice from at least three separate litters were analyzed
from both groups for each marker. Whole brains were cut coronally (18-μm-
thick sections) in the sampling plane, which was located at the thoracic level of
the forebrain. Control and experimental sections were matched by comparing
landmarks observed by counterstaining with fast red. Cell counts were obtainedfrom the sampling plane through the entire cortical VZ, SVZ or IMZ as
indicated, and all of the cells in each area were counted in these sections, except
in cases for which specific matched sub-regions are specified. Cells in both
cortices were counted systematically using a grid and 20× objective. The images
were collected with an Olympus microscope (Olympus BX51; Olympus, Japan)
and digital camera system (Olympus DP70; Olympus).
Results
FGF-2 induces the expression of Olig2 and PDGFRα in the
dorsal VZ and IMZ
To investigate the effects of FGF-2 on OLP generation
in vivo, FGF-2 was microinjected in utero into the cerebral
ventricles of E13.5 mouse forebrain. In situ hybridization for
Olig2 was carried out at E15.5 (Fig. 1). In normal brains
(Fig. 1D) or in those injected with vehicle alone (Fig. 1A),
Olig2+ cells were observed in the intermediate zone (IMZ) and
subventricular zone (SVZ) of the cortex. However, no Olig2
expression was observed in the ventricular zone (VZ) cells
lining the ventricles. In contrast, in FGF-2-injected brains, there
was a clear induction of Olig2 in the cells lining the ventricles
(Figs. 1B, arrows and insert, C) and a two-fold increase in the
number of Olig2+ cells in the IMZ of the cortex (Figs. 1B
arrowheads, C). Expression of Olig2 in the dorsal VZ cells was
observed in both hemispheres of the FGF-2-injected brains
since at the time of injection the ventricles are connected
(Supplementary Fig. 1).
Since in the forebrain Olig2 expression may not be restricted
to OLPs alone, we next analyzed the expression of PDGFRα, an
accepted marker of OLPs (Fig. 2). Similar to Olig2, in the
vehicle-injected controls, PDGFRα+ cells were observed in the
IMZ of the cortex but not in the VZ cells lining the ventricles. In
contrast, in FGF-2-injected brains, PDGFRα+ expression was
also observed in the VZ cells, notably those lining the ventricles
(Figs. 2B, arrows, insert, C). Furthermore, compared to
controls, a two-fold increase was also observed in the IMZ of
the cortex (Figs. 2B, arrowheads, C). These data demonstrate
that FGF-2 can induce the generation of OLPs from cortical
neuroepithelial cells of the VZ and increase the number of OLPs
in the IMZ.
Next, we asked whether the OLPs observed in the dorsal
VZ after FGF-2 injection originated from dorsal VZ cells or
migrated from ventral VZ of the adjacent lateral ganglionic
eminence (LGE). To address this question, we co-injected
pCX-Cre plasmids and FGF-2 into the lateral ventricles of
ROSA-GAP43-EGFP reporter transgenic mice then targeted
the plasmid into LGE at E13.5 by electroporation and analyzed
for the appearance of EGFP+ cells at E15.5 (Fig. 3). We have
recently shown that this procedure allows us to mark cells
with EGFP in specific locations of the neuroepithelial cells
lining the ventricular zones (Nakahira et al., 2006). In vehicle-
injected brains, while the area of EGFP+ cells marks the LGE
at the electroporation site, none of these cells migrated to the
dorsal cortex, as expected at this age. Similarly, in the FGF-2-
injected brains, as expected, there are numerous Olig2+ cells
present in the dorsal VZ, however, none is co-expressing
EGFP, ruling out the possibility that they migrated dorsally
Fig. 1. FGF-2 induces the expression of Olig2 mRNA in the dorsal forebrain. FGF-2 was microinjected in utero into the lateral ventricles at E13.5. Coronal sections of
brains injected with vehicle alone (A) or with FGF-2 (B) were analyzed by in situ hybridization for Olig2 mRNA at E15.5. Compared to controls, in FGF-2-injected
brains, Olig2 expression appeared in the VZ cells lining the ventricles (arrows and insert) and increased in the IMZ (arrowheads). The numbers of Olig2+ cells in the
cortical VZ and IMZ of the dorsal forebrain per section are quantified (C). (D). Coronal section of uninjected brain; ‘dorsal’ and ‘ventral’ regions of the forebrain are
specified. Scale bars in A, B, D = 200 μm. The numbers of brains analyzed were 16 for vehicle-injected and 21 for FGF-2-injected. Error bars, standard error of the
mean. *p < 0.001, **p < 0.05. VZ, ventricular zone; IMZ, intermediate zone; SVZ, subventricular zone; CP, cortical plate; GE, ganglionic eminence.
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induced generation of Olig2+ cells occurs from dorsal VZ
cells.
Dorsal OLPs induced by FGF-2 possess the potential to
mature into OLs
In order to ask if the FGF-2-induced expression of Olig2/
PDGFRα in the cortical VZ cells was indicative of OL
generation from this region, we examined the potential of VZ
cells to generate OL late progenitors that express antigen
recognized by the antibody O4, an OL-lineage restricted
marker (Fig. 4). Since PDGFRα+ OLPs do not mature into
O4+ late progenitors until E18.5 in vivo, a point at which it
is not possible to distinguish between dorsal VZ and ventrally
derived OLPs that have migrated dorsally into the cortex, we
addressed this question by analyzing explant cultures of
cortical VZ and SVZ. Specifically, following in utero injection
of FGF-2 into the lateral ventricles of E13.5 brains, we
harvested brains at E15.5 and dissected out the cortical region,
which corresponds to the region of PDGFRα+ cell (Figs. 4A,
B). These explants were cultured for 2–3 days in serum-free
media without exogenous FGF-2 and then immunolabeled
with O4 antibody. No O4+ OL late progenitors were observed
in vehicle-injected brain, even though the cultures were
healthy (Figs. 4C, F). In contrast, O4+ OL late progenitorsdid appear in VZ explants from FGF-2-injected brains
(Figs. 4D, E, G). Quantification showed that, compared to
controls, in each of the six sets of explants examined, the
numbers of O4+ OL late progenitors were increased in FGF-2-
injected brain (Fig. 4H). We conclude that OLPs induced by
FGF-2 in the cortical VZ possess the potential to mature into
oligodendrocytes.
Dorsal OLPs induced by FGF-2 are generated independent of
Shh signaling
In neuroepithelial cells cultured from E13 dorsal spinal
cord, FGF-2 induces the expression of Shh and the generation
of OLP (Gabay et al., 2003). We therefore asked whether the
FGF-2-mediated in vivo induction of Olig2/PDGFRα in the
cortical VZ of the dorsal forebrain was also due to the ectopic
induction at these locations of Shh and other ventral markers
such as Dlx2, Patched1 and Nkx2.1 (Fig. 5).
In situ hybridization analysis showed that, as expected, in
vehicle-injected controls, Dlx2 was expressed only ventrally
in the VZ of lateral ganglionic eminence and medial
ganglionic eminence (MGE), but not in the VZ of the cortex
(Fig. 5A arrowheads). Injection of FGF-2 in brains led to the
induction of Dlx2 in the dorsal VZ cells lining the ventricle
(Fig. 5A arrowheads). Characteristic induction of Olig2 in this
region, observed in serial sections, confirmed the success of
Fig. 2. FGF-2 induces expression of PDGFRαmRNA in the dorsal forebrain. FGF-2 was microinjected in utero into the lateral ventricles at E13.5. Coronal sections of
brains injected with vehicle alone (A) or with FGF-2 (B) were analyzed by in situ hybridization for PDGFRα mRNA at E15.5. Compared to controls, in FGF-2-
injected brains, PDGFRα cells appeared in the VZ lining the ventricles (arrows and insert) and increased in the IMZ (arrowheads). The numbers of PDGFRα cells in
the cortical VZ and IMZ of the dorsal forebrain per section are quantified (C). Scale bars in A, B = 200 μm. The numbers of brains analyzed were 16 for vehicle-
injected and 21 for FGF-2-injected. Error bars, standard error of the mean, *p < 0.001, **p < 0.05. VZ, ventricular zone; IMZ, intermediate zone; SVZ, subventricular
zone; CP, cortical plate; GE, ganglionic eminence.
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dorsal expression of the ‘ventral’ marker Dlx2.
In Nkx2.1-null mice, Shh of the ventral telencephalon is
absent and OLPs are not generated until E14.5, suggesting
that Nkx2.1 is required for early OLP generation from the
MGE (Nery et al., 2001). We therefore asked whether FGF-2Fig. 3. FGF-2-induced OLPs found in the dorsal VZ are not ventrally derived from
injected with either vehicle (A) or FGF-2 (B) into the lateral ventricles of transgenic EG
(LGE) by electroporation to mark the cells in this region with EGFP. At E15.5, the bra
Note that, in FGF-2-injected brains, the Olig2+ cells that appear in the dorsal VZ are
The numbers of brains analyzed were 4 for vehicle-injected and 7 for FGF-2-injecteregulated the expression of Nkx2.1. In both the vehicle- and
FGF-2-injected brains, the expression of Nkx2.1 was observed
in the ganglionic eminence (Fig. 5B arrow), but not dorsally
in the VZ of the cortex in the region of FGF-2-induced Olig2
expression (Fig. 5B arrowheads) [identified by analysis of
serial sections for Olig2 induction as above (data not shown)].the LGE. At E13.5, a plasmid coding for a Cre recombinase (pCx-Cre) was co-
FP indicator mice. pCx-Cre was then targeted to the lateral ganglionic eminence
ins were analyzed by double immunolabeling for Olig2 (red) and EGFP (green).
not EGFP+, suggesting their dorsal rather than ventral origin (B, arrows; insert).
d. Scale bars in A, B = 200 μm.
Fig. 4. OLPs induced by FGF-2 in the cortical VZ/SVZ have the potential to mature into OLs. At E13.5, FGF-2 or vehicle was injected into the lateral ventricles of the
mouse brain in utero. The most ventral region of the cortex, in which Olig2+ cells are expressed in response to FGF-2, was dissected out at E15.5 (A, box). The VZ/
SVZ regions were then separated from the IMZ to exclude any Olig2+ cells present in the IMZ (B). Examples of O4+ OL progenitors cultured for 2 days (C, D, F, G),
or more mature cells present at 3 days (E), in explants grown in serum-free media; Hoechst double staining (F, G) as a positive control for the presence of cells in the
field. (H) Quantification of the total numbers of O4+ cells per explant showed the appearance of O4+ cells in FGF-2, but not vehicle, treated groups. Scale bar, A,
B = 100 μm, C, D = 10 μm, E = 20 μm. VZ, ventricular zone; IMZ, intermediate zone; SVZ, subventricular zone; CP, cortical plate.
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forebrain by FGF-2 did not require the expression of Nkx2.1
in these regions.
We next asked if FGF-2 injection was directly inducing Shh
expression in the dorsal forebrain. In addition, we examined the
expression of Patched1, which when complexed with
smoothened forms a receptor complex relaying Shh signaling.
As shown previously, Shh mRNA was localized in thesurrounding VZ of MGE, while Patched1 was expressed in
cells near Shh expressing cells (Figs. 5C, D arrow). Neither of
these genes are expressed in either vehicle-injected control
dorsal cortex at E15.5 or in FGF-2-injected forebrains (Figs. 5C,
D arrowheads). Furthermore, to confirm that FGF-2 does not
require Shh signaling for induction of OLP from dorsal VZ
cells, we co-injected FGF-2 and Shh inhibitor cyclopamine into
the lateral ventricle of E13.5 mouse embryos and analyzed at
Fig. 5. FGF-2 induces Dlx2, but not Nkx2.1, Shh or Patched1 in the dorsal forebrain. Either FGF-2 or vehicle alone was injected in utero into the lateral ventricles at
E13.5, and coronal sections were analyzed at E15.5 by in situ hybridization for Dlx2, Olig2 (A), Nkx2.1 (B), Shh (C) or Patched1 (D). In vehicle-injected brain, Dlx2,
Nkx2.1, Shh and Patched1 were expressed normally in the ventral region (arrows). FGF-2 injection induced expression of Dlx2 in the cortical VZ (arrowheads)
corresponding to the region ofOlig2 expression (arrowheads in A). In contrast, neither Nkx2.1, Shh nor Patched1was induced in these regions (arrowhead in panels B,
C, D). Furthermore, inhibition of Shh signaling by co-injection of cyclopamine did not affect FGF-2-mediated induction of Olig2+ cells or PDGFRα mRNA+ cells
(arrow in E). Thus, FGF-2-induced generation of OLPs is independent of Shh signaling. The numbers of brains analyzed were 17 for vehicle-injected, 13 for FGF-2-
injected and 5 for FGF-2 plus cyclopamine co-injected. Scale bar in A, E = 200 μm, B, C, D = 500 μm.
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was able to induce the expression of Olig2 and PDGFRα in the
cells from the dorsal VZ (Fig. 5E, arrow). This suggests that the
cortical OLP generation by FGF-2 is independent of Shh
signaling in the dorsal cortex.
FGF-2 stimulates proliferation of cortical neuroepithelial cells
Finally, to examine the effect of FGF-2 on dividing cells in
the embryonic brain, BrdU was injected intraperitoneally topregnant mice (Fig. 6). Compared to vehicle-injected controls,
an increase in the number of BrdU positive cells was observed
in the dorsal cortex of FGF-2-injected forebrains (Figs. 6A, B).
Gradients of proliferation were observed in cells located 0–
250 μm from the ventricles, with VZ and SVZ region showing
maximum increases (Fig. 6C). Increased proliferation was also
evident by the appearance of a rough surface at the ventricular
wall due to the formation of small “neurosphere-like”
aggregates, which appeared to come out into the ventricles
(Fig. 6B arrows). Furthermore, lateral expansion of the VZ/SVZ
Fig. 6. FGF-2 stimulates proliferation of neuroepithelial cells in vivo. Vehicle (A) or FGF-2 (B) was injected into the lateral ventricles at E13.5 mouse brain. Three days
later, BrdU was injected intraperitoneally, embryos were collected 2 h after injection and sections were immunostained with anti-BrdU antibody. (C) The quantification
of BrdU positive cells was carried out as a function of the distance from the ventricle (VZ and SVZ covering 0–150 μm and IMZ covering 150 μm–250 μm). Scale
bars in A, B = 200 μm. The numbers of brains analyzed were 5 for vehicle-injected and 5 for FGF-2-injected. Error bars show standard error of the mean. GE,
ganglionic eminence.
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wall (Fig. 6B).
Discussion
The goal of this study was to understand the in vivo role
of FGF-2 on the development of OLs at a time when they are
first specified. We show that elevated levels of FGF-2 are
capable of inducing the production of OLPs in vivo from the
dorsal embryonic cerebral cortex and that this occurs in an
Shh-independent manner. This was determined by introducing
FGF-2 into the lateral ventricles of the mouse forebrain as
early as E13.5, an age at which OLPs are just originating at
specific loci in the ventral telencephalon and when there are
no OLPs in the dorsal cortex. Thus, it was possible to observethe effect of FGF-2 on the induction of OLP in the VZ of the
dorsal cortex and its effect on the first wave of migration of
OLP from ventral to dorsal telencephalon. Although FGF-2
has been injected into the brain previously (Vaccarino et al.,
1999), this was done at later time points after ventral to dorsal
migration had begun and the effect on OLPs was not
analyzed.
Effect of FGF-2 on OLP generation in the cortical VZ of the
dorsal forebrain
It is generally accepted that OLPs (Olig2+/PDGFR+)
originate in the ventral telencephalon (reviewed by Ross
et al., 2003) and that Shh regulates this process (Tekki-Kessaris
et al., 2001; Nery et al., 2001; Spassky et al., 2001; Rowitch
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telencephalic Shh expression (Nkx2.1-null mice) suggested
that there may also be Shh-independent pathways for generating
OLs in the forebrain (Nery et al., 2001). At least in the spinal
cord, a small population of OL progenitors is indeed generated
from the dorsal region in vivo (Cai et al., 2005; Fogarty et al.,
2005; Vallstedt et al., 2005), and these cells are generated
independently of Shh signaling. We asked if FGF-2 could fulfill
this role and if increasing the levels of FGF-2 in the ventricular
fluid would have an impact on OLP generation. The data
presented here suggest that FGF-2 does indeed have an effect on
generation of Olig2+/PDGFR+ OLPs in the dorsal forebrain.
Although the increase was observed both in the IMZ and VZ of
the cortex, the appearance in the VZ is particularly striking since
in normal development ventrally derived OLPs are never
observed in this region at E15.5. We conclude that this
induction of OLP in the cortical VZ reflects dorsally derived
OLP.
Dorsal spinal cord and cerebral cortical cells have been
reported to generate OLs, in culture, by treatment with FGF-2
(Chandran et al., 2003; Kessaris et al., 2004; Abematsu et al.,
2006). However, the relevance of these studies in the context
of in vivo generation has been questioned since this could
potentially be due to the deregulation in vitro of positional
cues by FGF-2 (Gabay et al., 2003). Our studies suggest that
FGF-2 is capable of inducing dorsal cortical cells to adopt an
OL fate, even in the presence of normal positional cues in
vivo.
What is the mechanism of dorsal generation of OLPs?
Several possible explanations are suggested. First, FGF-2
could in principle induce the expression of Shh in the dorsal
forebrain, which in turn may induce Olig2 and OLPs in this
region. However, Shh, Patched 1 or Nkx2.1 was not induced
by FGF-2. Furthermore, cyclopamine, an inhibitor of Shh
signaling, did not inhibit FGF-2-mediated generation of OLP
from the dorsal VZ, suggesting that FGF-2 induces dorsal
OLPs independently of the Shh signaling. Second, the lack of
dorsal OLP generation in normal brain could be due to the
fact that FGF-2 expression is low in dorsal, and high in
ventral, forebrain. Although it is not possible to accurately
determine the effective local levels of FGF-2 in vivo, no
dorsal–ventral variations in the intensity of FGF-2 immuno-
reactivity were observed at E13.5–15.5 (data not shown).
Third, increasing the levels of FGF-2 in the ventricles may
promote the generation of OLPs over neurons. In culture at
least, low doses of FGF-2 generate neurons from cortical
stem cells while higher doses produce OLPs (Temple and
Qian, 1995; Qian et al., 1997). Fourth, inhibitory factors such
as BMPs or Wnt present in the dorsal telencephalon act as
inhibitors of OLP generation (Grinspan et al., 2000; Yung
et al., 2002; Shimizu et al., 2005). Elevated levels of FGF-2
may be able to overcome these inhibitory factors and
facilitate OLP generation. Since these signals are present as
dorso-ventral gradients (Briscoe and Ericson, 1999; Miller
et al., 1999; Thomas et al., 2000; Mehler, 2002), it is likely
that their concentrations will be lowest near the dorso-ventral
boundary and thus easily negated by FGF-2 in this region.Consistent with this, the dorsal appearance of Olig2+/
PDGFR+ cells in the cortical VZ was most abundant in
the region closest to the ventral telencephalic boundary. Fifth,
normal levels of FGF-2 may not bind to all of its tyrosine
kinase receptors and activate all signaling pathways due to
the unavailability of correct co-receptors (heparan sulfate
proteoglycans) in the dorsal cortex (Nurcombe et al., 1993;
Ford-Perriss et al., 2002). At higher doses, FGF-2 can bind to
all receptors without the need for the correct co-receptor and
may thus activate pathways leading to Olig2 expression.
Overall, the induction ofOlig2+/PDGFR+ cells in the dorsal
VZ clearly shows that dorsal neuroepithelial cells have at least
the potential for generating OLPs under the influence of FGF-2
in an Shh-independent manner in vivo. Our results may
demonstrate a normal scenario of OLP generation from dorsal
neuroepithelial, whereby increasing the levels of FGF-2 simply
accelerates the time course of normal OLP generation from this
region. This hypothesis is consistent with recent reports of OLP
generation from the postnatal cortical neuroepithelial cells in
vivo (Gorski et al., 2002; Ivanova et al., 2003; Kessaris et al.,
2006). Thus, we propose that, while OLPs are generated from
ventral forebrain under the influence of Shh, a second wave of
OLP could be generated dorsally in the late embryonic/early
postnatal brain under the influence of higher doses of FGF-2
(Ivanova et al., 2003). In support of this, we have shown that
FGF receptors are expressed robustly in the VZ cells of not only
the ventral regions of MGE and LGE but also dorsally in the
cortex, of the embryonic brain and persist postnatally in the
germinal zones (Bansal et al., 2003). Thus, the level of the
ligand, rather than receptors, may be the limiting factor in
determining the generation of OLPs from the dorsal neuro-
epithelial cells at early embryonic ages. Unfortunately, it is not
possible to accurately determine the in vivo levels of growth
factors.
FGF-2 mediates an increase in the number of OLPs in the IMZ
of the cortex
Within 2 days after injection, FGF-2 delivered into the
ventricles at E13.5 causes a significant increase in the numbers
of OLPs in the cortical IMZ. IMZ is the accepted route of dorsal
migration of OLPs generated ventrally in the MGE. Thus, the
increased numbers of OLPs we observed in the dorsal IMZ
could be due to enhancement of the generation/migration of
OLPs originated in the ventral forebrain or, alternatively, to their
generation in the dorsal IMZ itself. Although our data cannot
distinguish between these two possibilities since the role of
FGF-2 in migration is well documented, we favor the former
(Klambt et al., 1992; Gisselbrecht et al., 1996; Osterhout et al.,
1997).
Effect of FGF-2 on proliferation of neuroepithelial cells in vivo
FGF-2 injection at E13.5 caused an increase in the number of
dividing cell in ventricular zone/subventricular zone. Our
results are consistent with those of Vaccarino et al. (1999)
who reported that the number of dividing cortical neuro-
271M. Naruse et al. / Developmental Biology 297 (2006) 262–273epithelial cells is decreased in FGF-2-null mice and increased
upon injection of FGF-2 into the ventricles of E15.5 mice. These
studies together suggest that endogenous FGF-2 is kept at an
appropriate concentration for maintaining the basal level of
proliferation of neural stem/progenitor cells.
In culture, FGF-2 is extensively used experimentally to
stimulate the proliferation of neuroepithelial progenitor cells
and to maintain them in an undifferentiated state as neuro-
spheres. The irregular surface of cells lining the ventricles,
and the appearance of “neurosphere-like” cell clumps that are
occasionally visualized coming out of the ventricular lining,
suggests a similar phenomenon exists in vivo. Interestingly,
“neurosphere-like” cell clumps that protrude into the ven-
tricles are also observed in the adult brain after the infusion of
epidermal growth factor (Kuhn et al., 1997; Doetsh et al.,
2002).
The present observation that FGF-2 leads to enlarged
ventricles without altering the thickness of the cortex
suggests that new cells are added in a plane parallel to the
ventricular wall, thereby expanding the VZ/SVZ laterally.
The alternative, whereby new cells arising from increased
proliferation of VZ/SVZ cells are added in a plane
perpendicular to ventricular wall, increasing the thickness
of the cortex and concomitantly reducing the size of the
ventricles, was not observed. Interestingly, enlarged lateral
ventricles in the forebrains are also observed in FGF receptor
gain of function transgenic mice for either FGFR3 (Inglis-
Broadgate et al., 2005) or FGFR2 (Dr. M.K. Hajihosseini,
Univ. of Birmingham, UK, unpublished observations). Taken
together, these observations show that FGF signaling is
important for the proliferation of neuroepithelial cells in vivo
and that enhancement of this signaling is most likely
responsible for the enlargement of the ventricles.
In summary, FGF-2 is capable of inducing dorsal cortical
cells to adopt an OL fate even in the presence of normal
positional cues in vivo. While previous studies have demon-
strated a role for FGF signaling in the postnatal terminal
differentiation of OLs (Oh et al., 2003; Murtie et al., 2005), this
is the first report demonstrating an in vivo role of FGF-2 in the
generation of OLPs in the embryonic forebrain as early as
E13.5–E15.5.
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